Cargando…
Elevated Lactate Dehydrogenase Has Prognostic Relevance in Treatment-Naïve Patients Affected by Chronic Lymphocytic Leukemia with Trisomy 12
Chronic Lymphocytic Leukemia (CLL) patients with +12 have been reported to have specific clinical and biologic features. We performed an analysis of the association between demographic; clinical; laboratory; biologic features and outcome in CLL patients with +12 to identify parameters predictive of...
Autores principales: | Autore, Francesco, Strati, Paolo, Innocenti, Idanna, Corrente, Francesco, Trentin, Livio, Cortelezzi, Agostino, Visco, Carlo, Coscia, Marta, Cuneo, Antonio, Gozzetti, Alessandro, Mauro, Francesca Romana, Frustaci, Anna Maria, Gentile, Massimo, Morabito, Fortunato, Molica, Stefano, Falcucci, Paolo, D’Arena, Giovanni, Murru, Roberta, Vincelli, Donatella, Efremov, Dimitar G, Ferretti, Antonietta, Rigolin, Gian Matteo, Vitale, Candida, Tisi, Maria Chiara, Reda, Gianluigi, Visentin, Andrea, Sica, Simona, Foà, Robin, Ferrajoli, Alessandra, Laurenti, Luca |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6678692/ https://www.ncbi.nlm.nih.gov/pubmed/31248056 http://dx.doi.org/10.3390/cancers11070896 |
Ejemplares similares
-
Morphological, immunophenotypic, and genetic features of chronic lymphocytic leukemia with trisomy 12: a comprehensive review
por: Autore, Francesco, et al.
Publicado: (2018) -
New developments in the management of chronic lymphocytic leukemia: role of ofatumumab
por: Laurenti, Luca, et al.
Publicado: (2016) -
The Use of Monoclonal Antibodies in the Treatment of Autoimmune Complications of Chronic Lymphocytic Leukemia
por: Laurenti, Luca, et al.
Publicado: (2013) -
Obinutuzumab plus chlorambucil versus ibrutinib in previously untreated chronic lymphocytic leukemia patients without TP53 disruptions: A real-life CLL campus study
por: Visentin, Andrea, et al.
Publicado: (2022) -
Measurable residual disease in chronic lymphocytic leukemia
por: Benintende, Giulia, et al.
Publicado: (2023)